[go: up one dir, main page]

CA1323565C - Methode et agents utilises pour eliminer les produits de la glycosylation avancee - Google Patents

Methode et agents utilises pour eliminer les produits de la glycosylation avancee

Info

Publication number
CA1323565C
CA1323565C CA 546737 CA546737A CA1323565C CA 1323565 C CA1323565 C CA 1323565C CA 546737 CA546737 CA 546737 CA 546737 A CA546737 A CA 546737A CA 1323565 C CA1323565 C CA 1323565C
Authority
CA
Canada
Prior art keywords
advanced glycosylation
agent
cells
animal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 546737
Other languages
English (en)
Inventor
Helen Vlassara
Michael Brownlee
Anthony Cerami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/091,534 external-priority patent/US4900747A/en
Application filed by Rockefeller University filed Critical Rockefeller University
Application granted granted Critical
Publication of CA1323565C publication Critical patent/CA1323565C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 546737 1986-09-12 1987-09-11 Methode et agents utilises pour eliminer les produits de la glycosylation avancee Expired - Fee Related CA1323565C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90774786A 1986-09-12 1986-09-12
US907,747 1986-09-12
US07/091,534 US4900747A (en) 1984-03-19 1987-09-03 Method and agents for removing advanced glycosylation endproducts
US91,534 1987-09-03

Publications (1)

Publication Number Publication Date
CA1323565C true CA1323565C (fr) 1993-10-26

Family

ID=26784059

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 546737 Expired - Fee Related CA1323565C (fr) 1986-09-12 1987-09-11 Methode et agents utilises pour eliminer les produits de la glycosylation avancee

Country Status (1)

Country Link
CA (1) CA1323565C (fr)

Similar Documents

Publication Publication Date Title
US4900747A (en) Method and agents for removing advanced glycosylation endproducts
EP0259893B1 (fr) Agents pour éliminer les produits terminaux de la glycosylation avancée
US5811075A (en) Method and agents for removing advanced glycosylation endproducts
Bennett et al. Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety.
Brownlee et al. Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.
AU681340B2 (en) Immunochemical detection of (in vivo) advanced glycosylation endproducts
EP0222313B1 (fr) Procédé et remèdes pour l'inhibition du vieillissement des protéines
Steinbrecher et al. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism
CA1208546A (fr) Freinage de la lipoproteine lipase par un mediateur induit par une endotoxine (epreuve de choc)
US4603106A (en) Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
Hemmings et al. Transport of large breakdown products of dietary protein through the gut wall.
Cerami et al. Protein glycosylation and the pathogenesis of atherosclerosis
JPH07503713A (ja) 蛋白質の高度グリコシル化阻害剤として有用なアミノ酸
JP3502125B2 (ja) 形質転換細胞の抽出および培養ならびにそれらに対する抗体の製造
US6309640B1 (en) Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
JPH09178740A (ja) 糖尿病または糖尿病合併症用マーカーとしての使用
Peter et al. Cell-mediated cytotoxicity during rejection and enhancement of allogeneic skin grafts in rats
IE44378B1 (en) Extracts of the haemopoietic system
SU1767433A1 (ru) Способ определени инсулинорезистентности имунного генеза у больных сахарным диабетом I типа
USRE35465E (en) Method and agents for removing advanced glycosylation endproducts
CA1323565C (fr) Methode et agents utilises pour eliminer les produits de la glycosylation avancee
Vlassara Chronic diabetic complications and tissue glycosylation: relevant concern for diabetes-prone black population
JP4319637B2 (ja) ボケからレクチンを含有するエキスの抽出方法、そのエキス、及びその抗腫瘍用医薬組成物、並びに細胞表面のグリコフォリンaの検出製剤と血液型検査キット
Hayde et al. Low-dose dietary L-arginine increases plasma interleukin 1α but not interleukin 1β in patients with diabetes mellitus
Balduini et al. Glycopeptides of erythrocyte membranes in some hematological disorders

Legal Events

Date Code Title Description
MKLA Lapsed